Secretome Therapeutics Announces Appointment of Angela Shen, M.D., M.B.A., to Board of Directors
DALLAS–(BUSINESS WIRE)–Secretome Therapeutics, a preclinical company developing novel therapies derived from neonatal mesenchymal stem cells, today announced the appointment of Angela Shen, M.D., M.B.A, to its Board of Directors. Dr. Shen is currently the Vice President, Strategic Innovation Leaders at Mass General Brigham and has served as Chief Medical Officer (CMO) at multiple venture-backed biotech … [Read more…]
